Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

London stocks slip as BoE slows bond purchases; AstraZeneca weighs

Published 18/06/2020, 08:29
Updated 18/06/2020, 17:00
© Reuters. FILE PHOTO: Signage is seen outside the entrance of the London Stock Exchange in London

By Susan Mathew

(Reuters) - UK shares fell on Thursday after the Bank of England's slowed the pace of its huge bond-buying programme, while a surge in coronavirus cases in the United States and China fanned fears of a second wave of infections.

The blue-chip FTSE 100 (FTSE) was down 0.5% following its strongest two-day percentage gain in two weeks on Wednesday.

The BoE said it saw signs that the British economy was recovering from a pandemic-induced slump. It raised its asset purchase target by 100 billion pounds, as expected, but disappointed markets as it said the increase should see it through to the end of the year.

"The risk (for asset purchases) was skewed to the upside," said Stefan Koopman, senior market economist at Rabobank.

"In light of these expectations, the (bank's) decision actually turned out a bit hawkish," he said, adding that Rabobank still sees a further increase beyond August.

AstraZeneca (L:AZN) weighed the most, down 2.2%. The European Commission is in advanced deal talks with Johnson & Johnson (N:JNJ) on its COVID-19 vaccine under development, sources told Reuters.

Last week, many euro zone countries said they had acquired 400 million potential vaccine doses from the British drugmaker for its potential COVID-19 shot.

The mid-cap FTSE 250 (FTMC) fell 0.4%, with real estate (FTUB8600), consumer stocks (FTNMX3530) (FTNMX3570) and mining and metal (FTNMX1770) (FTNMX1750) stocks leading declines.

The commodity-heavy FTSE 100 has rebounded more than 25% from a coronavirus-driven crash in March, but the index has still lagged both European and U.S. stock markets amid forecasts of the worst UK recession in three centuries.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Among individual stocks, homebuilder Taylor Wimpey (L:TW) tumbled 6.0% after raising 522 million pounds ($655 million) in a discounted share sale, while Carnival Corp (L:CCL) slipped 1.1% after it reported a quarterly net loss of $4.4 billion.

Prudential (L:PRU) jumped 2.7% after it sold a minority stake in its U.S. business, Jackson, to Apollo Global-backed Athene Holding (N:ATH) for $500 million.

Latest comments

It is not the case!  ... Markets have already discounted fears of an hypothetical second virus wave.
It'll be like this until the big money men have exhausted the means of making money from it and retail investors have got tired of following them like sheep. Then the big money men will move onto the next thing. Trump..will he get re-elected or not? Either way it'll be good for the stock market, and even better if he doesn't.
The actual second wave will hit around September, so get set to Sell US30 then 🤙🏼
Buy stocks you believe in and hold your nerve
this is why I do coke and *****3 times daily
What's going on man, one day stocks are optimism and then fears of 2nd wave. Are you guys serous?
it's all setup to trap retail investors,. don't invest now..wait for the crash
I stopped going by these non sense fake news, if anything I do the opposite now. just got few shares of crest Nicholson for a day trade and for the first time in days a trade of mine is green.
how can someone dislike this post.must be an idealist, someone who believes it's all unicorns and rainbows
Oh well
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.